Peptron, Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All 087010.KQ news ›Peptron ends Yuhan diabetes tech deal, keeps PT302 rights in South Korea
Peptron(087010) and Yuhan(000100) terminated a technology transfer contract for a diabetes treatment worth up to 4 billion won that they signed about 15 years ago. Unlike the original contract value, Peptron actually received only the 1…
Peptron Shares Plunge 27% as Lilly Research Pact Ends
No Commercial Deal Reached During Study Period Company Says It Will Keep Pursuing Commercialization Shares of Peptron (087010.KQ), a developer of long-acting injectable drugs, tumbled more than 27% after the company ended a joint research…
Peptron Ends Technology Evaluation with Eli Lilly; Stock Plunges Nearly 30% as Definitive Deal Fails to Materialize
Peptron (087010), a developer of long-acting injectable therapies, has concluded a two-year technology evaluation of its SmartDepot platform with global pharmaceutical company Eli Lilly. With no announcement of a follow-on…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- biz.chosun.com1
- en.sedaily.com1
- finance.biggo.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.